Cytotoxicity of sphingoid marine compound analogs in mono- and multilayered solid tumor cell cultures

Investigational New Drugs

Volumn 24, Issue 3, 2006, Pages 195-202

  Padrón, José M ^a,b,c   Peters, Godefridus J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Red Tematica de Investigacion Cooperativa en Cancer   (Spain)

^c HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

Author keywords

Multilayered postconfluent cultures; Pachastrissamine; Solid tumor; Sphinganine; Sphingosine; Spisulosine

Indexed keywords

AMINOALCOHOL; CISPLATIN; DIAMINE; FLUOROURACIL; GEMCITABINE; MILTEFOSINE; NATURAL PRODUCT; PACHASTRISSAMINE; SPHINGANINE; SPHINGOID DERIVATIVE; SPHINGOSINE; SPISULOSINE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CANCER RESISTANCE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL STRAIN A2780; CELL STRAIN WIDR; COLON CANCER; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG SCREENING; DRUG SELECTIVITY; DRUG SENSITIVITY; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; LEUKEMIA; LUNG CANCER; MARINE ENVIRONMENT; MONOLAYER CULTURE; MULTILAYERED POSTCONFLUENT CULTURE; OVARY CANCER; PRIORITY JOURNAL; SOLID TUMOR; SQUAMOUS CELL CARCINOMA; STANDARD; TUMOR CELL CULTURE;

ANTINEOPLASTIC AGENTS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; INHIBITORY CONCENTRATION 50; SPHINGOSINE;

EID: 33646553873     PISSN: 01676997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10637-005-3691-5     Document Type: Article

References (34)

1. Mayer AMS: Marine pharmacology in 1998: antitumor and cytotoxic compounds. The Pharmacologist 41: 159-164, 1999
2. Mayer AMS, Lehmann VKB: Marine pharmacology in 1999: antitumor and cytotoxic compounds. Anticancer Res 21: 2489-2500, 2001
3. Mayer AMS, Gustafson KR: Marine pharmacology in 2000: antitumor and cytotoxic compounds. Int J Cancer 105: 291-299, 2003
4. Mayer AMS, Gustafson KR: Marine pharmacology in 2001-2: antitumour and cytotoxic compounds. Eur J Cancer 40: 2676-2704, 2004
5. Rinehart KL, Fregeau NL, Warwick RA: US Patent No. 6107520, 1998
6. Kuroda I, Musman M, Ohtani II, Ichiba T, Tanaka J, Gravalos DG, Higa T: Pachastrissamine, a cytotoxic anhydrophytosphingosine from a marine sponge, Pachastrissa sp. J Nat Prod 65: 1505-1506, 2002
7. Ohta H, Yatomi Y, Sweeney EA, Hakomori S, Igarashi YA: Possible role of sphingosine in induction of apoptosis by tumor necrosis factor-α in human neutrophils. FEBS Lett 355: 267-270, 1994
8. Krown KA, Page MT, Nguyen C, Zechner D, Gutierrez V, Comstock KL, Glembotski CC, Quintana PJ, Sabbadini RA: Tumor necrosis factor α-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death. J Clin Invest 98: 2854-2865, 1996
9. Hung WC, Chang HC, Chuang LY: Activation of caspase-3-like proteases in apoptosis induced by sphingosine and other long-chain bases in Hep3B hepatoma cells. Biochem J 338: 161-166, 1999
10. del Olmo E, Macho A, Alves M, López JL, el Banoua F, Muñoz E, San Feliciano A: Long-chain aminoalcohol and diamine derivatives induce apoptosis through a caspase-3 dependent pathway. Bioorg Med Chem Lett 12: 2621-2626, 2002
11. Kokotos G, Padrón JM, Noula C, Gibbons WA, Martín VS: A general approach to the enantiomeric synthesis of lipidic α-amino acids and vicinal amino alcohols. Tetrahedron: Asymmetry 7: 857-866, 1996
12. Padrón JM, Kokotos G, Martín T, Markidis T, Gibbons WA, Martín VS: Enantiospecific synthesis of α-amino acid semialdehydes: a key step for the synthesis of unnatural unsaturated and saturated α-amino acids. Tetrahedron: Asymmetry 9: 3381-3394, 1998
13. Kokotos G, Padrón JM, Martín T, Gibbons WA, Martín VS: A general approach to the asymmetric synthesis of unsaturated lipidic α-amino acids. The first synthesis of α-aminoarachidonic acid. J Org Chem 63: 3741-3744, 1998
14. Padrón JM, Martín VS, Hadjipavlou-Litina D, Noula C, Constantinou-Kokotou V, Peters GJ, Kokotos G: Synthesis, in vitro cytotoxicity and in vivo anti-inflammatory activity of long chain 3-amino-1,2-diols. Bioorg Med Chem Lett 9: 821-826, 1999
15. Markidis T, Padrón JM, Martín VS, Peters GJ, Kokotos G: Synthesis and in vitro cytotoxicity of long chain 2-amino alcohols and 1,2-diamines. Anticancer Res 21: 2835-2840, 2001
16. Pizao PE, Peters GJ, van Ark-Otte J, Smets LA, Smitskamp-Wilms E, Winograd B, Pinedo HM, Giaccone G: Cytotoxic effects of anticancer agents on subconfluent and multilayered postconfluent cultures. Eur J Cancer 29A: 1566-1573, 1993
17. Padrón JM, van der Wilt CL, Smid K, Smitskamp-Wilms E, Backus HHJ, Pizao PE, Giaccone G, Peters GJ: The multilayered postconfluent cell culture as a model for drug screening. Crit Rev Oncol Hematol 36: 141-157, 2000
18. Skehan P, Storeng P, Scudeiro D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR: New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 82: 1107-1112, 1990
19. Keepers YP, Pizao PE, Peters GJ, van Ark-Otte J, Winograd B: Comparison of the sulforhodamine B protein and tetrazolium (MTT) assays for in vitro chemosensitivity testing. Eur J Cancer 27: 897-900, 1991
20. Lu Y, Han J, Scanlon KJ: Biochemical and molecular properties of cisplatin-resistant A2780 cells grown in folinic acid. J Biol Chem 263: 4891-4894, 1998
21. Ruiz van Haperen V, Veerman G, Eriksson S, Boven E, Stegmann A, Hermsen M, Vermorken JB, Pinedo HM, Peters GJ: Development and molecular characterization of 2′,2′-difluorodeoxycytidine resistant variant of the human ovarian carcinoma cell line A2780. Cancer Res 54: 4138-4143, 1994
22. Carey TE: Establishment of epidermoid carcinoma cell lines: In: Wittes RE (eds) Head and Neck Cancer. John Wiley & Sons, New York, 1985 pp 287-314.
23. Bergman AM, Ruiz van Haperen VWT, Veerman G, Kuiper CM, Peters GJ: Synergistic interaction between cisplatin and gemcitabine in vitro. Clin Cancer Res 2: 521-530, 1996
24. van Moorsel CJA, Veerman G, Bergman AM, Guechev A, Vermorken JB, Postmus PE, Peters GJ: Combination chemotherapy studies with gemcitabine. Seminars in Oncology 24(Suppl 7): 17-23, 1997
25. Pizao PE, Peters GJ, van Ark-Otte J, Smets LA, Smitskamp-Wilms E, Winograd B, Pinedo HM, Giaccone G: Cytotoxic effects of anticancer agents on subconfluent and multilayered postconfluent cultures. Eur J Cancer 29A: 1566-1573, 1993
26. The statistical analysis was done with the method "Resampling probability estimates for the difference between the means of two independent samples" accessible via Internet (http://faculty.vassar.edu/lowry/ VassarStats.html)
27. Niiro H, Azuma H, Tanago S, Matsumura K, Shikata K, Tachibana T, Ogino K: (3Z)-2-Acetylamino-3-octadecen-1-ol as a potent apoptotic agent against HL60 cells. Bioorg Med Chem 12: 45-51, 2004
28. Hoffmann TK, Leenen K, Hafner D, Balz V, Gerharz CD, Grund A, Ballo H, Hauser U, Bier H: Antitumor activity of protein kinase C inhibitors and cisplatin in human head and neck squamous cell carcinoma lines. Anticancer Drugs 13: 93-100, 2002
29. Dragusin M, Gurgui C, Schwarzmann G, Hoernschemeyer J, van Echten-Deckert G: Metabolism of the unnatural anticancer lipid safingol, L-threo- dihydrosphingosine, in cultured cells. J Lipid Res 44: 1772-1779, 2003
30. Tritton TR, Hickman J: How to kill cancer cells: membrane and cell signalling as targets in cancer chemotherapy. Cancer Cells 2: 95-105, 1990
31. Workman P: The cell membrane and cell signals: new targets for novel anticancer drugs. Ann Oncol 1: 100-111, 1990
32. Ahn EH, Schroeder JJ: Sphingoid bases and ceramide induce apoptosis in HT-29 and HCT-116 human colon cancer cells. Exp Biol Med 227: 345-353, 2002
33. Cuadros R, Montejo de Garcini E, Wandosell F, Faircloth G, Fernández-Sousa JM, Avila J: The marine compound spisulosine, an inhibitor of cell proliferation, promotes the disassembly of actin stress fibers. Cancer Lett 152: 23-29, 2000
34. Merrill AH, Nimkar S, Menaldino D, Hannun YA, Loomis C, Bell RM, Tyagi SR, Lambeth D, Stevens VL, Hunter R, Liottas DC: Structural requirements for long-chain (sphingoid) base inhibition of protein kinase C in vitro and for the cellular effects of these compounds. Biochemistry 28: 3138-3145, 1989